GET Real RAPS RAC-US Exam Questions With 100% Refund Guarantee Feb 02, 2024 [Q14-Q30]

Share

GET Real RAPS RAC-US Exam Questions With 100% Refund Guarantee Feb 02, 2024

Get Special Discount Offer on RAC-US Dumps PDF


Why RAPS RAC-US Certification Exam is tough to pass?

There are many factors that contribute to the failure of a RAC-US exam. The candidates can easily fix all of these, with the RAC-US exam dumps. Here are some of the reasons for the failure of the RAPS RAC-US Certification exam:

  • Improper practice: The candidates should take the practice exams on a regular basis. Candidates must ensure that they take the practice exams regularly.

  • Poor learning techniques: The candidates should learn and follow the proper study techniques. The candidates must spend a lot of time studying for the RAC-US Certification exam. Wellbeing crisis can also be a reason for failure. The candidates should be physically fit and have good mental health.

  • The mismanagement of time: The candidate should plan well to prepare for the RAC-US Certification exam. The candidate should give enough time to study for the RAC-US Certification exam. The intents and purposes should be set before studying for the RAC-US Certification.

  • Lack of proper study materials: The candidates must prepare themselves with the help of the proper study materials. The candidate must understand the concepts thoroughly before attempting the exam.

 

NEW QUESTION # 14
Company X is planning to acquire the rights for a product marketed by Company Y.
As part of due diligence, what is the MOST important information the Company X regulatory affairs professional should ask senior management to request from Company Y?

  • A. Safety issues
  • B. Clinical trial data
  • C. Intellectual properly
  • D. Marketing materials

Answer: A


NEW QUESTION # 15
A superiority advertising claim for a product versus its competitor's product can only be made under which of the following circumstances?

  • A. In vitro studies show the product to be superior.
  • B. Government survey data indicate the product is superior.
  • C. Results of adequate, well-controlled comparative clinical trial show the product is superior.
  • D. Results of a three-year, post-market patient survey indicate the product is superior.

Answer: C


NEW QUESTION # 16
The requirements for document control are located in which of the following documents?

  • A. IEC 60601
  • B. WHO guidelines
  • C. ICH guidelines
  • D. ISO 13485

Answer: D


NEW QUESTION # 17
The safety database for an anti-hypertensive drug consists of the following:
* 461 patients exposed for three months
* 343 patients exposed for six months
* 112 patients exposed for nine months
* 74 patients exposed for 12 months
Overall exposure is 2.000 patients. Which long-term ICH data requirement has NOT been met?

  • A. 3.000 total patient exposures
  • B. 100 patients for 12 months
  • C. 200 patients for nine months
  • D. 500 patients for three months

Answer: B


NEW QUESTION # 18
Which of the following is the PRIMARY purpose of an audit report?

  • A. To document compliance history
  • B. To train sales representatives
  • C. To define how to prepare new product submissions
  • D. To carry out a complete review of product applications

Answer: A


NEW QUESTION # 19
According to WHO, what are the temperature and humidity conditions for a Zone IVb long- term stability study?

  • A. 25: C and 60% RH
  • B. 30: C and 75% RH
  • C. 30 C and 35% RH
  • D. 30c C and 65% RH

Answer: B


NEW QUESTION # 20
The intermediate manufacturing process was changed during development of a pharmaceutical. The change may impact the API specification. Which functional area is responsible for the final approval of the change?

  • A. Quality
  • B. Regulatory
  • C. Production
  • D. Analytical

Answer: A


NEW QUESTION # 21
A process is ultimately validated to ensure which of the following?

  • A. The process meets the quality system requirements.
  • B. The process meets the regulatory requirements.
  • C. The process consistently produces the desired results.
  • D. The process consistently meets the desired Quantity standards

Answer: C


NEW QUESTION # 22
According to ISO 14971, what is the FIRST step when developing a risk management plan for a medical device?

  • A. Risk control
  • B. Risk management
  • C. Risk analysis
  • D. Risk estimation

Answer: C


NEW QUESTION # 23
Which of the following statements regarding the off-label use of drugs is CORRECT?

  • A. Sponsors are allowed to distribute publications about unapproved uses of approved drugs and devices as long as the marketing application is under review by the regulatory authority.
  • B. The regulatory authority does not restrict physician prescribing for off-label indications or regulate the manufacturer's promotion for such use.
  • C. The peer-reviewed literature can ensure high-quality off-label promotion of medications, thereby increasing access to much needed drugs and devices.
  • D. Although the regulatory authority reviews and approves drugs for specific indications, the approval does not limit the use of those drugs in clinical practice.

Answer: D


NEW QUESTION # 24
The regulatory authority in Country X issued a request for a mandatory product recall in
Country X due to serious injuries to patients. This product also is distributed in Country Y.
What should the regulatory affairs professional of the product's manufacturer FIRST do in
Country Y?

  • A. Draft a formal letter to customers in Country Y about this recall.
  • B. Initiate a mandatory recall of the product in Country Y.
  • C. Prepare the legal team in Country Y for possible litigations.
  • D. Review alt distribution records and complaints reported in Country Y.

Answer: D


NEW QUESTION # 25
What are the MOST important elements that global regulatory agencies want to know before approving a new product for sale in their countries?

  • A. Safety and failure risk
  • B. Quality and effectiveness
  • C. Safety and effectiveness
  • D. Quality and failure risk

Answer: C


NEW QUESTION # 26
Which of the following double-blind clinical trial designs would be MOST appropriate for a
Phase III study with a new product intended to treat an acute life-threatening disease with less than optimal available therapy?

  • A. Cross-over
  • B. Dose-ranging
  • C. Placebo-controlled
  • D. Active-controlled

Answer: A


NEW QUESTION # 27
A manufacturer is involved in a recall event process for a plasma-derived product. From which stage should the manufacturer be able to trace back the product?

  • A. Plasma fractionation
  • B. Plasma pooling
  • C. Individual plasma donation
  • D. Product distribution

Answer: D


NEW QUESTION # 28
A materials supplier informs a company that it intends to stop supplying a material critical to the manufacture of the company's products. What action should the company take FIRST?

  • A. Complete a gap analysis to identify options.
  • B. Qualify another supplier and execute a supplier agreement.
  • C. Reformulate the products with a replacement material.
  • D. Review the company's existing Quality Management System

Answer: B


NEW QUESTION # 29
Company X encounters challenges in the global life cycle management of its medical devices. Which of the following Is MOST appropriate for improving product life cycle management?

  • A. Plan regulatory approval update meetings with senior management and stakeholders.
  • B. Initiate a global submission process after all submission data are finalized.
  • C. Utilize the STED template to complete global requirements.
  • D. Identify countries where special requirements exist during the product development phase.

Answer: D


NEW QUESTION # 30
......


The RAC-US exam is a highly respected certification that demonstrates a regulatory professional's knowledge and expertise in the complex and constantly evolving field of regulatory affairs. Passing the exam requires extensive preparation and study, but it can lead to new career opportunities and greater recognition within the industry. The RAC-US exam is an essential step for regulatory professionals who want to advance their careers and make a significant contribution to the development and regulation of safe and effective products and services.


Why do I need to take RAPS RAC-US Certification Exam?

Naturally, you are eager to have an opportunity to become RAC-US certified, right? Well, it is because the RAC-US certification program is an excellent way for healthcare regulatory professionals to show that they are a leader in the regulatory field. It is also one of the most difficult regulatory exams in the world today. The RAC-US Certification represents the most competitive and rigorous professional certification in the healthcare sector. This is a must for all regulatory professionals who are looking for a path to advancement in their careers. They can get help from the RAC-US exam dumps to solve the exam. Board of trustees membership is not enough; if you want to be a leader in the industry, then you should be RAC-US certified.

 

PDF Download RAPS Test To Gain Brilliante Result!: https://testking.itexamsimulator.com/RAC-US-brain-dumps.html